Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Short rib-polydactyly syndrome type III (SRTD3), also known as asphyxiating thoracic dystrophy 3, is a perinatal lethal autosomal recessive skeletal ciliopathy characterized by a narrow thorax, shortened long bones, and post-axial polydactyly. Next-generation sequencing studies have identified biallelic DYNC2H1 variants as the molecular cause of SRTD3.
Genetic analyses across 12 unrelated probands from eight families revealed compound heterozygous or homozygous variants in DYNC2H1, including missense, frameshift, and splice-site changes. Representative variants include c.10711_10714del (p.Phe3571ArgfsTer5) (PMID:27323140). Parental segregation confirmed recessive inheritance in each case.
Phenotypic presentations consistently feature a constricted thoracic cage (HP:0000774) and polydactyly (HP:0010442) with variable skeletal and visceral anomalies. Prenatal ultrasound often detects thoracic hypoplasia and limb shortening, supporting early diagnosis.
Functional characterization through RNA sequencing and minigene splicing assays demonstrated aberrant splicing, intron retention, and significantly reduced DYNC2H1 transcript levels, consistent with loss-of-function pathogenicity (PMID:37489014)(PMID:36442996).
No significant conflicting evidence has been reported. The collective genetic and experimental data support a haploinsufficiency mechanism underlying DYNC2H1-associated SRTD3.
The definitive association of biallelic DYNC2H1 variants with asphyxiating thoracic dystrophy 3 underpins the use of targeted sequencing and RNA-based assays for accurate prenatal diagnosis and informed genetic counseling.
Gene–Disease AssociationStrong12 probands across multiple families with confirmed biallelic DYNC2H1 variants and perinatal lethal presentation consistent with asphyxiating thoracic dystrophy (PMID:27323140)(PMID:29458881) Genetic EvidenceStrong12 probands from 8 unrelated families harbor compound heterozygous or homozygous DYNC2H1 variants including missense, frameshift, and splice alleles (PMID:27323140)(PMID:37007936) Functional EvidenceModerateRNA sequencing and minigene splicing assays demonstrate aberrant splicing, intron retention, and decreased DYNC2H1 expression consistent with loss-of-function mechanism (PMID:37489014)(PMID:36442996) |